Emily Rothbaum Perito

Emily Rothbaum Perito

Auto-generated profile, based on publicly available information

Emily Rothbaum Perito

Department of Pediatrics, University of California, San Francisco, CA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Transplantation
Verified
Journal Article
Closed access
EPEmily R. Md Perito
Emily R. Md Perito
GRGarrett Roll
Garrett Roll
JDJennifer L. Dodge
Jennifer L. Dodge
SRSue Rhee
Sue Rhee
JRJohn P. Roberts
John P. Roberts
Background.: In the United States, 1 in 10 infants and 1 in 20 older children die on the liver transplant waiting list. Increasing split liver transplantation could increase organ availability for these children, without decreasing transplants in adults. Methods.: Using United Network for Organ Sharing Standard Transplant Analysis and Research data, we identified livers transplanted 2010 to 2015 that could potentially have been used for split transplant, based on strict criteria. Livers not suitable for pediatric patients or allocated to high-risk recipients were excluded. Number and distribution of potentially “split-able” livers were compared to pediatric waitlist deaths in each region. Results.: Of 37 333 deceased donor livers transplanted, 6.3% met our strict criteria for utilization in split liver transplant. Only 3.8% of these were actually utilized for split liver transplantation. 96% were used for a single adult recipient. Of the 2253 transplanted as whole livers, 82% of their recipients were listed as willing to accept a segmental liver, and only 3% were listed as requiring a cold ischemia time less than 6 hours. Over the same 5 years, 299 children died on the waitlist. In every United Network for Organ Sharing region, there were more potentially “split-able” livers than pediatric waitlist deaths. Thirty-seven percent of pediatric waitlist deaths occurred at transplant centers that averaged 1 or less pediatric split liver transplantation annually during the study period. Conclusions.: This comparison, although not conclusive, suggests that we might be missing opportunities to reduce pediatric waitlist mortality without decreasing access for adults—using split liver transplant. Barriers are significant, but further work on strategies to increase split liver transplant is warranted.

12 August 2020 in Hepatology
Verified
Journal Article
Closed access
PDF file
SFSandy Feng
Sandy Feng
JBJohn C. Bucuvalas
John C. Bucuvalas
GMGeorge V. Mazariegos
George V. Mazariegos
JMJohn C. Magee
John C. Magee
ASAlberto Sanchez‐Fueyo
Alberto Sanchez‐Fueyo
ADAnthony J. Demetris
Anthony J. Demetris

1 February 2018 in Environmental Health
Verified
Journal Article
Open access
PDF file
SVSofia G. Verstraete
Sofia G. Verstraete
JWJanet Wojcicki
Janet Wojcicki
EPEmily R. Perito
Emily R. Perito
PRPhilip Rosenthal
Philip Rosenthal
Bisphenol-A (BPA) is a ubiquitous chemical and recognized endocrine disruptor associated with obesity and related disorders. We explored the association between BPA levels and suspected non-alcoholic fatty liver disease (NAFLD). Unweighted analyses were used to study the relationship between urinary BPA levels and suspected NAFLD (alanine aminotransferase (ALT). > 30 U/L, body mass index (BMI) Z-score > 1.064 and evidence of insulin resistance) using National Health and Nutrition Examination Survey (NHANES) data (2003–2010) on 12–19 year olds. Unweighted and weighted analyses were used to evaluate the risk with only elevated ALT. We included 944 adolescents with urinary BPA and fasting laboratory tests from a total of 7168 adolescents. Risk of suspected NAFLD was increased in the second quartile of BPA levels (1.4–2.7 ng/mL) when compared to the first (< 1.4 ng/mL) (Odds Ratio (OR) 4.23, 95% Confidence Interval (CI) 1.44–12.41). The ORs for the third and second quartiles were positive but did not reach statistical significance. The association was stronger in Hispanics (n = 344) with BPA levels in the second (OR 6.12, 95% C.I. 1.62–23.15) quartile and when limiting the analyses to overweight/obese adolescents (n = 332), in the second (OR 5.56, 95% C.I. 1.28–24.06) and fourth BPA quartiles (OR 6.85, 95% C.I. 1.02–46.22) compared to the first quartile. BPA levels were not associated with ALT elevation. The risk of suspected NAFLD is increased in participants in higher quartiles of BPA exposure, particularly in those of Hispanic ethnicity. Further studies are required to fully understand the potential role of BPA in non-alcoholic fatty liver disease.

3 November 2020 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
EPEmily R. Perito
Emily R. Perito
JSJames E. Squires
James E. Squires
DBDavid Bray
David Bray
JBJohn Bucuvalas
John Bucuvalas
CKCassandra Krise‐Confair
Cassandra Krise‐Confair
GMGeorge V. Mazariegos
George V. Mazariegos

23 May 2016 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
HBH. J. Braun
H. J. Braun
EPE. R. Perito
E. R. Perito
JDJ. L. Dodge
J. L. Dodge
SRS. Rhee
S. Rhee
JRJ. P. Roberts
J. P. Roberts
Nonstandard exceptions requests (NSERs), in which transplant centers appeal on a case‐by‐case basis for Pediatric End‐Stage Liver Disease/Mayo End‐Stage Liver Disease points, have been highly utilized for pediatric liver transplant candidates. We evaluated whether NSE outcomes are associated with waitlist and posttransplant mortality. United Network for Organ Sharing (UNOS) Scientific Registry of Transplant Recipients data on pediatric liver transplant candidates listed in 2009–2014 were analyzed after excluding those granted automatic UNOS exceptions. Of 2581 pediatric waitlist candidates, 44% had an NSE request. Of the 1134 children with NSERs, 93% were approved and 7% were denied. For children 2–18 years at listing, NSER denial increased the risk of waitlist mortality or removal for being too sick (subhazard ratio 2.99, 95% confidence interval [CI] 1.26–7.07, p = 0.01 in multivariate analysis). For children younger than 2 years, NSER denial did not impact waitlist mortality/removal. Children with NSER approved had reduced risk of graft loss 3 years posttransplant in univariate but not multivariable analysis (odds ratio 0.73, 95% CI 0.53–1.01, p = 06). Those with NSER denial had a higher risk of posttransplant death than those with no NSER (hazard ratio 2.43, 95% CI 0.99–5.95, p = 0.05, multivariable analysis), but NSER approval did not impact posttransplant death. Further research on NSER utilization in pediatric liver transplant is needed to optimize organ allocation and outcomes for children.

17 July 2017 in Hepatology Communications
Verified
Journal Article
Open access
PDF file
EPEmily R. Perito
Emily R. Perito
VAVeeral Ajmera
Veeral Ajmera
NBNathan M. Bass
Nathan M. Bass
PRPhilip Rosenthal
Philip Rosenthal
JLJoel E. Lavine
Joel E. Lavine
BABradley Aouizerat
Bradley Aouizerat
Reliable noninvasive markers to characterize inflammation, hepatocellular ballooning, and fibrosis in nonalcoholic fatty liver disease (NAFLD) are lacking. We investigated the relationship between plasma cytokine levels and features of NAFLD histology to gain insight into cellular pathways driving nonalcoholic steatohepatitis (NASH) and to identify potential noninvasive discriminators of NAFLD severity and pattern. Cytokines were measured from plasma obtained at enrollment in pediatric participants in NASH Clinical Research Network studies with liver biopsy‐proven NAFLD. Cytokines were chosena priorias possible discriminators of NASH and its components. Minimization of Akaike information criterion was used to determine cytokines retained in multivariable models. Of 235 subjects, 31% had “Definite NASH” on liver histology, 43% had “Borderline NASH,” and 25% had NAFLD but not NASH. Total plasminogen activator inhibitor 1 (PAI1) and activated PAI1 levels were higher in pediatric participants with Definite NASH and with lobular inflammation. Interleukin‐8 (IL‐8) was higher in those with stage 3‐4 fibrosis and lobular inflammation. Soluble IL‐2 receptor alpha was higher in children with stage 3‐4 fibrosis and portal inflammation. In multivariable analysis, PAI1 variables were discriminators of Borderline/Definite NASH, Definite NASH, lobular inflammation, and ballooning. IL‐8 increased with steatosis and fibrosis severity; soluble IL‐2 receptor alpha increased with fibrosis severity and portal inflammation. IL‐7 decreased with portal inflammation and fibrosis severity.Conclusion: Plasma cytokines associated with histology varied considerably among NASH features, suggesting promising avenues for investigation. More targeted analysis is needed to identify the role of these markers in NAFLD and to evaluate their potential as noninvasive discriminators of disease severity. (Hepatology Communications2017;1:609–622)